Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an application requesting Agency review and de novo classification of the Early Bird® Bleed Monitoring System.